Netflix Shares Drop After Earnings, and the Top Biotech Analyst Dissects the Race for a COVID Cure
Netflix stock dropped after the company posted disappointing subscriber growth and earnings for the latest quarter. Plus results from Snap and Texas Instruments. And Institutional Investor’s Top-Rated Biotech Analyst breaks down the outlook for companies racing to bring a coronavirus vaccine to market. And a moment of…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from CNBC's "Fast Money"
See all episodes →Key week for retail on deck... And the next test for housing stocks 8/14/26
Record national debt as stocks keep climbing…and retail investor playbook 8/13/26
AI stocks back in the spotlight... And a bold call for three rate hikes this year 8/12/26
Similar episodes from other shows
More like CNBC's "Fast Money" →
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.